A Case of Drug Hepatopathy which was Suspected of HBV Reactivation during Oral Cancer Therapy

2014 ◽  
Vol 27 (1) ◽  
pp. 56-60
Author(s):  
TADAHIKO YANAGITA ◽  
SHUNGO FURUDOI ◽  
YOSHIKI ISHIDA ◽  
TAKAHIDE KOMORI
BMJ Open ◽  
2022 ◽  
Vol 12 (1) ◽  
pp. e055814
Author(s):  
Alessandro Passardi ◽  
Patrizia Serra ◽  
Orazio Caffo ◽  
Carla Masini ◽  
Erika Brugugnoli ◽  
...  

IntroductionONCO-TreC platform consists of a mobile application delivered to patients as electronic diary and a web-based dashboard managed by healthcare professionals. We aim to compare the effectiveness of ONCO-TreC electronic diary with a standard paper diary, in improving adherence to oral cancer therapy in patients with solid and haematological tumours.Methods and analysisThis is an open label, superiority, randomised controlled trial conducted in two Italian oncology units. Patients will be randomised with a 1:1 ratio to electronic or paper diary. For both groups a counsellor will be responsible for drug and diary delivery. The evaluation period will end after six cycles of therapy. The primary aim is to compare the proportion of non-adherent patients in the two arms. Adherence will be measured through pill count; anyone who takes less than 90% of the total prescribed drug dose will be considered non-adherent. Assuming a percentage of non-adherent patients to oral therapy of 40% in arm B, and a 60% reduction in this percentage in arm A, a sample of 124 patients will provide 80% power to identify an absolute difference greater than 24 percentage points using a bilateral Fisher’s exact test with a significance level of 0.05. Considering a dropout rate of 10%, approximately 136 patients will have to be enrolled. The primary analysis will be performed on the intention-to-treat population. Secondary aims are to describe the reasons for non-adherence, the level of satisfaction of patients and healthcare professionals with the paper and electronic diary, and the impact of non-adherence in terms of healthcare costs.Ethics and disseminationEthical approval was obtained from Romagna Ethics Committee (CEROM), study ID 2108, prot. n. IRST 100.28 of 10/04/2020. Informed consent will be obtained from all study participants. Findings will be disseminated through peer-reviewed journals, conferences and event presentations.Protocol versionVersion 2, 6 April 2021.Trial registration numberNCT04826458.


1979 ◽  
Vol 138 (4) ◽  
pp. 508-511 ◽  
Author(s):  
Zelig H. Lieberman ◽  
D.Lamar Byrd ◽  
Tommy J. Davidson
Keyword(s):  

2017 ◽  
Vol 526 (1-2) ◽  
pp. 225-234 ◽  
Author(s):  
Suyeong Nam ◽  
Jeong-Jun Lee ◽  
Song Yi Lee ◽  
Jae Young Jeong ◽  
Wie-Soo Kang ◽  
...  

2018 ◽  
Vol 25 (1) ◽  
pp. 107327481876787
Author(s):  
Matthew Kelling ◽  
Lubomir Sokol ◽  
Samir Dalia

Chronic active hepatitis B infection (HBV) has been implicated in lymphomagenesis of non-Hodgkin lymphoma (NHL). Treatment of cancer including NHL with chemotherapy or immunotherapy can lead to HBV reactivation in previously infected patients. Serological testing of HBV prior to initiation of this therapy is recommended by several national and international medical agencies and expert panels. Patients with positive hepatitis B surface antigen (HBsAg) and anti-hepatitis B core antibody (anti-HBc ab) need to start antiviral therapy with entecavir or tenofovir prior to initiation of chemotherapy or immunotherapy and continue this treatment for 6 to 12 months after completion of cancer therapy to avoid late HBV reactivation. Monitoring of HBV DNA viral load and liver function tests should be done during cancer therapy in infected patients. Hepatitis B infection vaccination resulted in decreases prevalence of HBV virus carriers and decreased incidence of virus-induced malignancies.


Toukeibu Gan ◽  
2017 ◽  
Vol 43 (3) ◽  
pp. 388-392
Author(s):  
Mioko Matsuo ◽  
Rina Jiromaru

2016 ◽  
Vol 23 (Suppl 1) ◽  
pp. A233.1-A233
Author(s):  
T Gramage Caro ◽  
E Delgado Silveira ◽  
N Vicente Oliveros ◽  
MI Muñoz Ojeda ◽  
T Bermejo Vicedo

2017 ◽  
Vol 57 ◽  
pp. 58-66 ◽  
Author(s):  
Anna Rachelle Mislang ◽  
Tanya M. Wildes ◽  
Ravindran Kanesvaran ◽  
Capucine Baldini ◽  
Holly M. Holmes ◽  
...  

2015 ◽  
Vol 9 (8) ◽  
pp. 1720-1735 ◽  
Author(s):  
Gunjan Srivastava ◽  
Ajay Matta ◽  
Guodong Fu ◽  
Raj Thani Somasundaram ◽  
Alessandro Datti ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document